| Product Code: ETC7741846 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Malaria Vaccine Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Malaria Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Malaria Vaccine Market - Industry Life Cycle |
3.4 Japan Malaria Vaccine Market - Porter's Five Forces |
3.5 Japan Malaria Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Japan Malaria Vaccine Market Revenues & Volume Share, By Agent, 2021 & 2031F |
3.7 Japan Malaria Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Japan Malaria Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Japan Malaria Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidences of malaria in Japan |
4.2.2 Growing awareness about the importance of vaccination against malaria |
4.2.3 Government initiatives to prevent and control malaria outbreaks |
4.3 Market Restraints |
4.3.1 High cost of vaccine development and production |
4.3.2 Limited public funding for malaria vaccination programs |
4.3.3 Regulatory challenges in vaccine approval process |
5 Japan Malaria Vaccine Market Trends |
6 Japan Malaria Vaccine Market, By Types |
6.1 Japan Malaria Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Malaria Vaccine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Japan Malaria Vaccine Market Revenues & Volume, By Pre-Erythrocytic Vaccine, 2021- 2031F |
6.1.4 Japan Malaria Vaccine Market Revenues & Volume, By Erythrocytic Vaccine, 2021- 2031F |
6.1.5 Japan Malaria Vaccine Market Revenues & Volume, By Multi-Antigen Vaccine, 2021- 2031F |
6.2 Japan Malaria Vaccine Market, By Agent |
6.2.1 Overview and Analysis |
6.2.2 Japan Malaria Vaccine Market Revenues & Volume, By Plasmodium Falciparum, 2021- 2031F |
6.2.3 Japan Malaria Vaccine Market Revenues & Volume, By Plasmodium Vivax, 2021- 2031F |
6.2.4 Japan Malaria Vaccine Market Revenues & Volume, By Anopheles Species, 2021- 2031F |
6.3 Japan Malaria Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Japan Malaria Vaccine Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.3.3 Japan Malaria Vaccine Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.4 Japan Malaria Vaccine Market Revenues & Volume, By Intradermal, 2021- 2031F |
6.4 Japan Malaria Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Japan Malaria Vaccine Market Revenues & Volume, By NGO/Non-Profit Organization, 2021- 2031F |
6.4.3 Japan Malaria Vaccine Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.4 Japan Malaria Vaccine Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.5 Japan Malaria Vaccine Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Japan Malaria Vaccine Market Import-Export Trade Statistics |
7.1 Japan Malaria Vaccine Market Export to Major Countries |
7.2 Japan Malaria Vaccine Market Imports from Major Countries |
8 Japan Malaria Vaccine Market Key Performance Indicators |
8.1 Number of malaria cases reported annually in Japan |
8.2 Percentage of population vaccinated against malaria |
8.3 Funding allocated by the government towards malaria prevention programs |
9 Japan Malaria Vaccine Market - Opportunity Assessment |
9.1 Japan Malaria Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Japan Malaria Vaccine Market Opportunity Assessment, By Agent, 2021 & 2031F |
9.3 Japan Malaria Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Japan Malaria Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Japan Malaria Vaccine Market - Competitive Landscape |
10.1 Japan Malaria Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Japan Malaria Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here